Search | IOVS | ARVO Journals

Showing 1 – 20 of 40

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar Study

Rupert Wolfgang Strauss; Xiangrong Kong; Beatriz E Munoz; Sheila K West; Michael S Ip; Alexander Ho; Anamika Jha; Paul S Bernstein; David G Birch; Artur V Cideciyan; Michel Michaelides; José-Alain Sahel; Janet S Sunness; Elias I Traboulsi; Eberhart Zrenner; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1568. doi:

ARVO Annual Meeting Abstract July 2018

Assessment of visual impairment and eye diseases in HIV-infected people in the ART era in Rakai, Uganda

Xiangrong Kong; Stephanie Irwin; Joseph Ssekasanvu; Beatriz E Munoz; Sheila K West; Gertrude Nakigozi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4108. doi:

ARVO Annual Meeting Abstract September 2016

Visual acuity loss during one year in Stargardt Disease: ProgStar Prospective Study

Xiangrong Kong; Rupert Wolfgang Strauss; Ann-Margret Ervin; Paul S Bernstein; Artur V Cideciyan; Janet S Sunness; Elias I Traboulsi; Beatriz E Munoz; Mohamed Ahmed; Sheila K West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Results from spectral-domain optical coherence tomography (SD-OCT) at baseline compared with normative data: The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study

Alexander Ho; Beatriz E Munoz; Rupert Wolfgang Strauss; Anamika Jha; Ngoc Lam; Zhihong Hu; David G Birch; Eberhart Zrenner; Sheila K West; Srinivas R Sadda; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2697. doi:

ARVO Annual Meeting Abstract September 2016

Performance of the Icare Home (TA022) self-tonometer.

Lucy I Mudie; Sophie LaBarre; Sezen Karakus; Beatriz E Munoz; David S Friedman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6438. doi:

ARVO Annual Meeting Abstract September 2016

Associations between fundus autofluorescence and spectral-domain optical coherence tomography in Stargardt disease at baseline of the prospective ProgStar study.

Yulia Wolfson; Beatriz E Munoz; Rupert Wolfgang Strauss; Alexander Ho; Anamika Jha; Elias I Traboulsi; Artur V Cideciyan; Michel Michaelides; Srinivas R Sadda; Sheila K West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Evaluation of Surveillance Tools for Trachoma in Two Districts in Nepal

Andrea Isabela Zambrano; Beatriz E Munoz; Shekhar Sharma; Sailesh Mishra; Laura Dize; Katherine Crowley; Lisa Rotondo; Sheila K West

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2349. doi:

ARVO Annual Meeting Abstract September 2016

Progression of visual acuity and fundus autofluorescence in recent onset Stargardt disease: ProgStar study

Sheila K West; Xiangrong Kong; Beatriz E Munoz; Artur V Cideciyan; Michel Michaelides; Ann-Margret Ervin; Srinivas R Sadda; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2687. doi:

ARVO Annual Meeting Abstract September 2016

The natural history of the progression of atrophy secondary to Stargardt disease type 4 (Progstar-4 Study): Baseline demographics and ocular characteristics of patients with PROM-1 related retinal dystrophy.

Syed Mahmood Ali Shah; Mohamed Ahmed; Nadia Junaid; Saghar Bagheri; Beatriz E Munoz; Rupert Wolfgang Strauss; Etienne M. Schonbach; Michel Michaelides; Ann-Margret Ervin; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2695. doi:

ARVO Annual Meeting Abstract September 2016

Barriers to accessing surgery for trachomatis trichiasis in Kongwa, Tanzania

Ryan James Bickley; Harran Mkocha; Beatriz E Munoz; Sheila K West

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Baseline characteristics of subjects enrolled in the trial of lutein and zeaxanthin supplementation and its effect on macular pigment in albinism (LUVIA Study: Lutein for Vision in Albinism)

Saghar Bagheri; Yulia Wolfson; Beatriz E Munoz; Ann-Margret Ervin; Mohamed A Ibrahim; Mary Frey; Simrat K Sodhi; Syed Mahmood Ali Shah; Sheila K West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5158. doi:

ARVO Annual Meeting Abstract June 2015

Evaluating the Utility of Postoperative Photos as Educational Tools in Trichiasis Surgery Training

Richard Sidney Dykstra; Shannath L Merbs; Beatriz E Munoz; Emily W Gower

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):137. doi:

ARVO Annual Meeting Abstract June 2015

Pre-operative Eyelash Location Predicts Long-term Trichiasis Surgery Success

Emily W Gower; Beatriz E Munoz; Saul Rajak; Shannath L Merbs; Esmael Ali; Matthew John Burton

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):6203. doi:

ARVO Annual Meeting Abstract June 2015

Once Trachoma is gone, what tools can we use for surveillance?

Sheila K West; Beatriz E Munoz; Jerusha Weaver; Zakayo Mrango; Laura Dize; Charlotte Gaydos; Thomas Quinn; Diana Martin; Andrea Zambrano

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):6204. doi:

ARVO Annual Meeting Abstract June 2015

The Natural History of the Progression of Atrophy secondary to Stargardt Disease studies (ProgStar): yearly progression rate of atrophic lesions in the retrospective study

Rupert Wolfgang Strauss; Beatriz E Munoz; Alexander Ho; Yulia Wolfson; Srinivas R Sadda; Xiangrong Kong; Sheila K West; Hendrik P Scholl; ProgStar study group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):894. doi:

ARVO Annual Meeting Abstract June 2015

Assessment of Macular Function with Microperimetry (MP1) in Patients with Stargardt Disease

Mohamed Ibrahim; Rupert Wolfgang Strauss; Yulia Wolfson; Xiangrong Kong; Beatriz E Munoz; Alexander Ho; Srinivas R Sadda; Sheila K West; Hendrik P Scholl; ProgStar Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):895. doi:

ARVO Annual Meeting Abstract June 2015

Measuring Severe Inflammatory Trachoma (TI) when prevalence is low provides indirect data on infection with C. trachomatis in endemic communities .

Andrea Isabela Zambrano; Beatriz E Munoz; Laura Dize; Harran Mkocha; Charlotte Gaydos; Thomas Quinn; Sheila K West

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4060. doi:

ARVO Annual Meeting Abstract June 2015

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Associations between Fundus Autofluorescence and Microperimetry at Baseline of the Prospective Study

Xiangrong Kong; Rupert Wolfgang Strauss; Beatriz E Munoz; Yulia Wolfson; Ann M Ervin; Srinivas R Sadda; Sheila K West; Hendrik P Scholl; The ProgStar study group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2584. doi:

ARVO Annual Meeting Abstract June 2015

Fundus Autofluorescence Characteristics in the Natural History of the Progression of Atrophy secondary to Stargardt Disease (PROGSTAR) Study

Syed Mahmood Shah; Xiangrong Kong; Alexander Ho; Srinivas R Sadda; Beatriz E Munoz; Rupert Wolfgang Strauss; Mohamed Ibrahim; Yulia Wolfson; Sheila K West; Hendrik P Scholl; PROGSTAR study group.

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1652. doi:

ARVO Annual Meeting Abstract June 2015

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Baseline Demographics and Ocular Characteristics

Ann-Margret Ervin; Beatriz E Munoz; Rupert Wolfgang Strauss; Yulia Wolfson; Xiangrong Kong; Sheila K West; Hendrik P Scholl; ProgStar Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1781. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Progression of Stargardt disease as measured by spectral-domain optical coherence tomography (SD-OCT) in the ProgStar Study

Assessment of visual impairment and eye diseases in HIV-infected people in the ART era in Rakai, Uganda

Visual acuity loss during one year in Stargardt Disease: ProgStar Prospective Study

Results from spectral-domain optical coherence tomography (SD-OCT) at baseline compared with normative data: The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study

Performance of the Icare Home (TA022) self-tonometer.

Associations between fundus autofluorescence and spectral-domain optical coherence tomography in Stargardt disease at baseline of the prospective ProgStar study.

Evaluation of Surveillance Tools for Trachoma in Two Districts in Nepal

Progression of visual acuity and fundus autofluorescence in recent onset Stargardt disease: ProgStar study

The natural history of the progression of atrophy secondary to Stargardt disease type 4 (Progstar-4 Study): Baseline demographics and ocular characteristics of patients with PROM-1 related retinal dystrophy.

Barriers to accessing surgery for trachomatis trichiasis in Kongwa, Tanzania

Baseline characteristics of subjects enrolled in the trial of lutein and zeaxanthin supplementation and its effect on macular pigment in albinism (LUVIA Study: Lutein for Vision in Albinism)

Evaluating the Utility of Postoperative Photos as Educational Tools in Trichiasis Surgery Training

Pre-operative Eyelash Location Predicts Long-term Trichiasis Surgery Success

Once Trachoma is gone, what tools can we use for surveillance?

The Natural History of the Progression of Atrophy secondary to Stargardt Disease studies (ProgStar): yearly progression rate of atrophic lesions in the retrospective study

Assessment of Macular Function with Microperimetry (MP1) in Patients with Stargardt Disease

Measuring Severe Inflammatory Trachoma (TI) when prevalence is low provides indirect data on infection with C. trachomatis in endemic communities .

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Associations between Fundus Autofluorescence and Microperimetry at Baseline of the Prospective Study

Fundus Autofluorescence Characteristics in the Natural History of the Progression of Atrophy secondary to Stargardt Disease (PROGSTAR) Study

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Baseline Demographics and Ocular Characteristics

To View More...

You must be signed into an individual account to use this feature.